Gadolinium-associated plaques: A new, distinctive clinical entity

JAMA Dermatology

Volumn 151, Issue 3, 2015, Pages 316-319

  Gathings, Robert M ^a   Reddy, Raveena ^a   Cruz, Daniel Santa ^b   Brodell, Robert T ^a,c  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b WCP Laboratories Inc   (United States)

^c UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE DIPROPIONATE PLUS CLOTRIMAZOLE; BLOOD CLOTTING FACTOR 13A; CD34 ANTIGEN; CD68 ANTIGEN; CLOBETASOL DIPROPIONATE; GADODIAMIDE; GLUCOCORTICOID; HEMOSIDERIN; MUCIN; TRIAMCINOLONE ACETONIDE; UNCLASSIFIED DRUG; VIMENTIN; CONTRAST MEDIUM; GADOLINIUM PENTETATE;

AGED; ANNULAR ELASTOLYTIC GRANULOMA; ARTICLE; CASE REPORT; DIFFERENTIAL DIAGNOSIS; DRUG TREATMENT FAILURE; EXPOSURE; FEMALE; GADOLINIUM ASSOCIATED PLAQUE; GRANULOMA ANNULARE; GRANULOMATOUS SKIN DISEASE; HAND; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LOWER LEG; MALE; NEPHROGENIC SYSTEMIC FIBROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PAPULE; PRIORITY JOURNAL; PRURITUS; PUNCH BIOPSY; RASH; SARCOIDOSIS; SCLEROTIC BODY; SKIN DEFECT; SKIN DISCOLORATION; SKIN FIBROSIS; STROMA CELL; VERY ELDERLY; CALCINOSIS; CHEMICALLY INDUCED; DRUG ERUPTIONS; ERYTHEMA; PATHOLOGY;

AGED; AGED, 80 AND OVER; CALCINOSIS; CONTRAST MEDIA; DRUG ERUPTIONS; ERYTHEMA; FEMALE; GADOLINIUM DTPA; HUMANS; MALE;

EID: 84924705861     PISSN: 21686068     EISSN: 21686084     Source Type: Journal    
DOI: 10.1001/jamadermatol.2014.2660     Document Type: Article

References (12)

1. Deng A, Martin DB, Spillane A, et al. Nephrogenic systemic fibrosis with a spectrum of clinical and histopathological presentation: a disorder of aberrant dermal remodeling. J Cutan Pathol. 2010;37(2):204-210.
2. Bhawan J, Perez-Chua TA, Goldberg L. Sclerotic bodies beyond nephrogenic systemic fibrosis. J Cutan Pathol. 2013;40(9):812-817.
3. Kartono F, Basile A, Roshdieh B, Schwimer C, Shitabata PK. Findings of osseous sclerotic bodies: a unique sequence of cutaneous bone formation in nephrogenic systemic fibrosis. J Cutan Pathol. 2011;38(3):286-289.
4. Bhawan J, Swick BL, Koff AB, Stone MS. Sclerotic bodies in nephrogenic systemic fibrosis: a new histopathologic finding. J Cutan Pathol. 2009;36(5):548-552.
5. Grekin SJ, Holcomb MJ, Modi GM, Huttenbach YT, Poythress EL, Diwan AH. Lollipop lesions in nephrogenic systemic fibrosis mimicking a deep fungal infection. J Cutan Pathol. 2012;39(11):981-984.
6. Penfield JG, Reilly RF Jr. What nephrologists need to know about gadolinium. Nat Clin Pract Nephrol. 2007;3(12):654-668.
7. Idée JM, Port M, Medina C, et al. Possible involvement of gadolinium chelates in the pathophysiology of nephrogenic systemic fibrosis: a critical review. Toxicology. 2008;248(2-3):77-88.
8. Hershko K, Hull C, Ettefagh L, et al. A variant of nephrogenic fibrosing dermopathy with osteoclast-like giant cells: a syndrome of dysregulated matrix remodeling? J Cutan Pathol. 2004;31(3):262-265.
9. Ruiz-Genao DP, Pascual-Lopez MP, Fraga S, Aragüés M, Garcia-Diez A. Osseous metaplasia in the setting of nephrogenic fibrosing dermopathy. J Cutan Pathol. 2005;32(2):172-175.
10. Girardi M, Kay J, Elston DM, Leboit PE, Abu-Alfa A, Cowper SE. Nephrogenic systemic fibrosis: clinicopathological definition and workup recommendations. J Am Acad Dermatol. 2011;65(6):1095, e7.
11. Ortonne N, Lipsker D, Chantrel F, Boehm N, Grosshans E, Cribier B. Presence of CD45RO+ CD34+ cells with collagen synthesis activity in nephrogenic fibrosing dermopathy: a new pathogenic hypothesis. Br J Dermatol. 2004;150(5):1050-1052.
12. Pryor JG, Scott GA. Nephrogenic systemic fibrosis: a clinicopathologic study of 6 cases. J Am Acad Dermatol. 2007;57(5):902-903.